◼ Archived
Business
🔮 Newsylist predicts: still trending tomorrow medium confidence — graded ✗ wrong
RK Mellon Foundation pledges $25M to launch rare disease therapy hub in Pittsburgh - Pittsburgh Post-Gazette
5sources
5articles
14velocity
+0%since first seen
5d agofirst detected
How fast it spread
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Sources (5)
- Pittsburgh set to become rare disease research hub with $25M investment 90.5 WESA · 5d ago
- Rare Ventures, a First-of-its-kind Platform for Accelerating Rare Disease Therapies, Launches in Pittsburgh Carnegie Mellon University · 5d ago
- Pittsburgh-based start-up targets rare diseases with Mellon Foundation grant that could hit $25M TribLIVE.com · 5d ago
- Exclusive | Most Rare Diseases Have No Approved Drug. This Accelerator Aims to Help WSJ · 5d ago
- RK Mellon Foundation pledges $25M to launch rare disease therapy hub in Pittsburgh Pittsburgh Post-Gazette · 5d ago broke it first
Related trends
↓ Cooling
Business
Gen X Retirement Savings: Typical Balances, Gaps, and Why Many Fall Short of Benchmarks
Nearly 20% of Gen X workers do not plan to stop working, amid rising costs and retirement gaps.
↓ Cooling
Business
🔮 fades
Credit card issuer Synchrony partners with OpenAI for ChatGPT shopping
Credit card issuer Synchrony has partnered with OpenAI to bring store cards and shopping offers into ChatGPT.
↑ Rising
Business
🔮 holds
The Surprising Reason This Biotech Plummeted 69%
EyePoint Pharmaceuticals shares cratered following a late-stage trial setback for its flagship eye disease drug.
↓ Cooling
Business
🔮 fades
China's recovery sputters as consumption, output lose steam
China's economic recovery is losing momentum as retail sales, output, and investment slow down.
↑ Rising
Business
🔮 holds
Alibaba to Sell Videogame Business for at Least $1.5 Billion
Alibaba moves to sell its videogame business to prioritize artificial intelligence and e-commerce.
🔥 Breakout ↑ Rising
Business
🔮 fades
Big investors hunt for tomorrow's AI winners as capex angst fades
Major investors are shifting focus toward emerging artificial intelligence opportunities as capital expenditure concerns diminish.